FormWeb • chlordiazePOXIDE-amitriptyline

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

chlordiazePOXIDE-amitriptyline

chlordiazePOXIDE-amitriptyline

Therapeutic Interchange Miscellaneous

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Limbitrol	TABLET, ORAL	5 mg-12.5 mg, 10 mg-25 mg

Comments:

Limbitrol medication guide

Interchange to individual components at the same dose and frequency. Amitriptyline 10 mg will be utilized for 12.5 mg doses.

Updated: February 2023 (Limbitrol)

Last updated: Mar. 20, 2023

Black Box Warning: amitriptyline: Suicidal ideation in children, adolescents
Black Box Warning: chlordiazePOXIDE: Risks From Concomitant Use With Opioids

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.